Skip to main content
. 2023 Apr 12;93(5):580–590. doi: 10.2319/110622-760.1

Table 2.

Summary of Overall Quality of Evidence of Studies Included in Each Meta-analysis Using GRADE:


Certainty Assessment

Outcome

Number of Studies

Study Design

Risk of Bias

Inconsistency

Indirectness

Imprecision

Others

Certainty
Chewing gum vs pharmacological agents 7 RCTs Seriousa Seriousb Seriousc Not serious Not serious ⊕○○○ Very low
Chewing gum vs placebo 4 RCTs Seriousa Seriousd Not serious Seriouse Not serious ⊕○○○ Very low
Chewing gum vs hard bite wafer 2 RCTs Seriousa Seriousf Not serious Seriouse Not serious ⊕○○○ Very low
a 

Downgraded due to unclear or absence of blinding of both patients and outcome assessors.

b 

Downgraded due to high heterogeneity (P < .00001); I2 = 88%.

c 

Downgraded due to the inclusion of studies that reported mean pain at 24 h in females only.

d 

Downgraded due to moderate level of heterogeneity; I2 = 44%.

e 

Downgraded due to small sample size.

f 

Downgraded due to small number of studies and imprecise I2.